Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 149

Results For "rating"

1828 News Found

Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar
Biotech | April 04, 2022

Intas and Axantia sign an exclusive agreement for Ranibizumab biosimilar

Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US


Croda secures financial support from UK Government for expansion of lipid systems manufacturing facility
News | April 04, 2022

Croda secures financial support from UK Government for expansion of lipid systems manufacturing facility

The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines


Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment
News | April 03, 2022

Bayer to invest €1.3 billion for driving innovations in life sciences, agriculture segment

Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024


Panacea Biotec appoints NK Juneja as additional director
People | April 03, 2022

Panacea Biotec appoints NK Juneja as additional director

He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations


Bayer to set up 27 telemedicine centres across eight states
Sustainability | April 01, 2022

Bayer to set up 27 telemedicine centres across eight states

Bayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya


Wipro GE Healthcare launches facility under govt’s PLI scheme
News | April 01, 2022

Wipro GE Healthcare launches facility under govt’s PLI scheme

It is one of the 15 medical device manufacturers approved under the government’s PLI scheme


Oragnon enters global licencing agreement with Dare Biosciences
News | April 01, 2022

Oragnon enters global licencing agreement with Dare Biosciences

An estimated 21 million American women experience BV


HealthQuad raises US $ 162 million in second fund
Startup | March 31, 2022

HealthQuad raises US $ 162 million in second fund

The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe


Symbiance announces the launch of SimpleStats to help pharma and biotech industries
Digitisation | March 31, 2022

Symbiance announces the launch of SimpleStats to help pharma and biotech industries

It is an application to automate statistical analysis and reporting for clinical research.


USFDA approves Edwards Mitris Resilia valve
Medical Device | March 31, 2022

USFDA approves Edwards Mitris Resilia valve

The valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve